IL257195A - New forms of apermilest and the process for their preparation - Google Patents

New forms of apermilest and the process for their preparation

Info

Publication number
IL257195A
IL257195A IL257195A IL25719518A IL257195A IL 257195 A IL257195 A IL 257195A IL 257195 A IL257195 A IL 257195A IL 25719518 A IL25719518 A IL 25719518A IL 257195 A IL257195 A IL 257195A
Authority
IL
Israel
Prior art keywords
apremilast
making
same
novel forms
novel
Prior art date
Application number
IL257195A
Other languages
English (en)
Hebrew (he)
Original Assignee
Scinopharm Taiwan Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scinopharm Taiwan Ltd filed Critical Scinopharm Taiwan Ltd
Publication of IL257195A publication Critical patent/IL257195A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/50—Iso-indoles; Hydrogenated iso-indoles with oxygen and nitrogen atoms in positions 1 and 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/4035—Isoindoles, e.g. phthalimide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL257195A 2015-08-28 2018-01-28 New forms of apermilest and the process for their preparation IL257195A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562211280P 2015-08-28 2015-08-28
US201662279147P 2016-01-15 2016-01-15
PCT/SG2016/050413 WO2017039537A1 (en) 2015-08-28 2016-08-25 Novel forms of apremilast and the process of making the same

Publications (1)

Publication Number Publication Date
IL257195A true IL257195A (en) 2018-03-29

Family

ID=58097541

Family Applications (1)

Application Number Title Priority Date Filing Date
IL257195A IL257195A (en) 2015-08-28 2018-01-28 New forms of apermilest and the process for their preparation

Country Status (9)

Country Link
US (1) US9765026B2 (OSRAM)
EP (1) EP3341360A4 (OSRAM)
JP (1) JP2018528948A (OSRAM)
KR (1) KR20180036791A (OSRAM)
CN (1) CN107922332A (OSRAM)
CA (1) CA2994217A1 (OSRAM)
IL (1) IL257195A (OSRAM)
TW (1) TWI613191B (OSRAM)
WO (1) WO2017039537A1 (OSRAM)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016174685A1 (en) * 2015-04-27 2016-11-03 Mylan Laboratories Limited Process for the enantiomeric resolution of apremilast intermediates
US10544097B2 (en) * 2015-08-27 2020-01-28 Msn Laboratories Private Limited Solid state forms of N-[2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]acetamide and process for preparation thereof
CN106977444B (zh) * 2016-01-18 2021-10-08 重庆医药工业研究院有限责任公司 一种阿普斯特无定型的制备方法
HUE065223T2 (hu) * 2016-03-30 2024-05-28 Sarudbhava Formulations Private Ltd Apremilaszt gyógyszerkészítményei
CN107686461A (zh) * 2016-08-04 2018-02-13 广东东阳光药业有限公司 阿普斯特的溶剂化物及其制备方法和用途
WO2019021303A1 (en) * 2017-07-23 2019-01-31 Alkem Laboratories Limited NOVEL PROCESS FOR THE PREPARATION OF APREMILAST IN AMORPHOUS FORM
CN108440381A (zh) * 2018-03-15 2018-08-24 威海迪素制药有限公司 一种阿普斯特新晶型h及其制备方法
EP4330230A1 (en) * 2021-04-26 2024-03-06 Amgen Inc. Process for synthesizing apremilast
WO2023120466A1 (ja) * 2021-12-23 2023-06-29 沢井製薬株式会社 アプレミラスト水和物含有製剤

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8093293B2 (en) 1998-07-06 2012-01-10 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin conditions
US6962940B2 (en) 2002-03-20 2005-11-08 Celgene Corporation (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof
US7893101B2 (en) 2002-03-20 2011-02-22 Celgene Corporation Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof
WO2007053503A1 (en) * 2005-11-01 2007-05-10 Janssen Pharmaceutica N.V. Substituted dihydroisoindolones as allosteric modulators of glucokinase
DK2276483T3 (da) 2008-03-27 2014-06-10 Celgene Corp Faste former, omfattende (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindolin-1,3-dion, sammensætninger deraf og anvendelser deraf
MX2011012122A (es) * 2009-05-14 2012-02-28 Tianjin Hemay Bio Tech Co Ltd Derivados de tiofeno.
EP2723717A2 (en) * 2011-06-24 2014-04-30 Amgen Inc. Trpm8 antagonists and their use in treatments
US8981117B2 (en) 2012-09-14 2015-03-17 Celgene Corporation Processes for the preparation of isoindole compounds and isotopologues thereof
UY35103A (es) * 2012-10-29 2014-05-30 Glaxo Group Ltd Compuestos de cefem 2-sustituidos
EP2730278A1 (en) * 2012-11-08 2014-05-14 Ratiopharm GmbH Composition melt
IN2014MU01283A (OSRAM) 2014-04-04 2015-10-09 Cadila Healthcare Ltd
CN104447445B (zh) 2014-12-05 2016-07-06 新发药业有限公司 一种合成阿普斯特中间体的制备方法
MX2017015151A (es) 2015-05-26 2018-08-15 Lupin Ltd Un proceso mejorado para la preparación de apremilast y novedosos polimorfos del mismo.
BR112017026560A2 (pt) * 2015-06-09 2018-08-14 Dr Reddys Laboratories Ltd processo para preparação de apremilast e seus intermediários.

Also Published As

Publication number Publication date
US9765026B2 (en) 2017-09-19
WO2017039537A1 (en) 2017-03-09
EP3341360A1 (en) 2018-07-04
EP3341360A4 (en) 2019-01-23
TW201718485A (zh) 2017-06-01
KR20180036791A (ko) 2018-04-09
TWI613191B (zh) 2018-02-01
CA2994217A1 (en) 2017-03-09
CN107922332A (zh) 2018-04-17
US20170057916A1 (en) 2017-03-02
JP2018528948A (ja) 2018-10-04

Similar Documents

Publication Publication Date Title
ZA201701244B (en) Carrier-antibody compositions and methods of making and using the same
SG11201704626TA (en) Aqueous coating composition and process of making the same
IL257195A (en) New forms of apermilest and the process for their preparation
IL290742A (en) Graphene and production of graphene
GB201516516D0 (en) Process of manufacture
PL3490988T3 (pl) Nowy związek i sposób
GB201519128D0 (en) Solid forms and methods of preparing the same
SG11202004381WA (en) Production of guaiene and rotundone
IL251885A0 (en) Noscapinoid-Producing Bacteria and Methods for Their Preparation and Use
SG11201802816TA (en) Natural colorants and processes of making the same
ZA201900689B (en) New composition and process
IL267172A (en) Compositions containing methylphenidate prodrugs, processes for their preparation and use
SG11201803485UA (en) Method for producing silazane-siloxane copolymers and the use of such copolymers
IL250554A0 (en) Improved substrates that promote bone growth and methods of making them
ZA201601869B (en) Improved process for the preparation of apremilast
GB2575196B (en) Thieno pyridimine compounds and manufacture of the same
GB201502983D0 (en) Composition and process
ZA201608823B (en) Processes for the preparation of azd5363 and novel intermediate used therein
IL253077A0 (en) Process and intermediates for the preparation of Fermpanel
GB201700973D0 (en) Process of manufacture
GB201612252D0 (en) New composition and new process
GB201709464D0 (en) Process and composition
GB201709996D0 (en) Improved composition and process
GB201509277D0 (en) Production of 3-alkylphenols and uses thereof
GB201600187D0 (en) 3rd law of time - de-constructed